Cellectis S.A. current report, Q2 FY2023

Cellectis S.A. Form 6-K Summary

Business Context and Reporting Period

This Form 6-K was filed by Cellectis S.A., a foreign private issuer headquartered in Paris, France, on April 17, 2023. The filing serves to distribute a press release dated April 17, 2023, to U.S. investors. The document does not contain a full financial report for a specific fiscal period but rather acts as a conduit for the referenced press release.

Key Financial Metrics

The filing text provided does not contain specific financial data. There are no reported values for revenue, profit, cash flow, margins, debt, or liquidity within this document. The filing solely references the existence of a press release as Exhibit 99.1.

Material Changes

No material changes versus prior periods are detailed in the text of this filing. The document does not provide comparative financial data or operational updates beyond the reference to the press release.

Guidance, Outlook, and Risks

The filing text does not include management commentary, financial guidance, outlook, risk factors, or contingencies. These details are presumably contained within the attached press release (Exhibit 99.1), which is not included in the input text.

Investor Verification Checklist

  • Verify the content of the press release dated April 17, 2023 (Exhibit 99.1) to understand the specific corporate event or announcement.
  • Confirm whether the press release contains updated financial guidance or material operational changes.
  • Review the company's most recent Form 20-F for the latest audited financial statements, as this 6-K does not provide them.